TY  - JOUR

T1  - High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial

JO  - The Lancet Oncology

PY  - 2014/01/01

AU  - Cook G

AU  - Parrish C

AU  - O'Connor S

AU  - Williams C

AU  - Brown JM

AU  - Cairns DA

AU  - Fletcher M

AU  - Chalmers A

AU  - Cavenagh J

AU  - Snowden JA

AU  - Ashcroft AJ et al

ED  - 

DO  - DOI: 10.1016/S1470-2045(14)70245-1

Y2  - 2024/12/26

ER  -